BioCity and MSD Enter Clinical Collaboration for BC3195 and Keytruda Combination Trial
China-based BioCity Biopharmaceutics Co., Ltd. announced a clinical collaboration agreement with US-based giant Merck, Sharp...
BioCity Biopharma
BioCity Biopharma Launches Phase III Study for Kidney Disease Drug SC0062
BioCity Biopharma, a leading biopharmaceutical company, has announced the initiation of a Phase III clinical...
BioCity Biopharma Achieves Full Enrollment in Phase II Study of SC0062 for IgA Nephropathy
BioCity Biopharma, a Chinese biotechnology company, has announced the completion of enrollment for all 120...
BioCity Biopharma Partners with AstraZeneca for Phase Ib/II Study in Hepatocellular Carcinoma
China-based biotech firm BioCity Biopharma has entered into a clinical study partnership with UK pharmaceutical...
BioCity Biopharma Receives FDA IND Approval for CD3-EGFR BsAb BC3448
China-based biotechnology company BioCity Biopharma has announced that it has received Investigational New Drug (IND)...